Skip to main content
European Heart Journal Supplements: Journal of the European Society of Cardiology logoLink to European Heart Journal Supplements: Journal of the European Society of Cardiology
. 2019 Dec 31;21(Suppl M):M61–M63. doi: 10.1093/eurheartj/suz213

Producing an effective care plan in advanced heart failure

Loreena Hill 1,
PMCID: PMC6937515  PMID: 31908620

Abstract

An effective discharge plan is associated with better outcomes in advanced heart failure (HF) patients. Furthermore, a patient-centred care planning can improve patients’ satisfaction, quality of life, and enhance self-care. Telemedicine may allow optimized monitoring of advanced HF patients. Nevertheless, its implementation into clinical practice across European countries is still limited. This document reflects the key points discussed concerning effective management plans in advanced HF by a panel of experts during a Heart Failure Association meeting on physiological monitoring of the complex multimorbid HF patient.

Keywords: Heart failure, Care plan

Introduction

Care planning may be defined as a strategy designed to guide healthcare professionals involved with patient care.1 Such plans should be individualized and aimed at improving outcomes during the course of patients’ care. This is especially challenging in advanced and complex multimorbid heart failure (HF) patients.2 For this reason, a multidisciplinary panel of leading international experts was organized by the Heart Failure Association of the European Society of Cardiology (ESC) to discuss the latest evidence, ongoing research and recommendations on physiological monitoring of the complex multimorbid HF patient. This document reflects the key points on ‘Producing an effective care plan in advanced HF’ as part of this meeting.

Goals of the discharge plan in advanced heart failure

Planning for discharge is an important component of the HF patient’s hospital stay, particularly in multimorbid patients or those in the advanced stages of their disease. Studies have shown that effective discharge planning, performed by a multidisciplinary team, can reduce rehospitalization rates and improve mortality3–5 through better communication and patient care across disciplines, clinical specialties, and geographical boundaries.6,7 Indeed, an earlier discharge can be facilitated when there is a collaborative approach involving the patient, secondary care HF professionals, and social and primary care teams.8

The ultimate goal is being to provide a ‘seamless’ system of care ensuring optimal patient management, no matter where the patient begins or continues their healthcare journey, resulting in better outcomes.9

Thus, the development of an effective plan of care for patients with advanced HF should be the responsibility of the multidisciplinary HF team, ideally commenced on diagnosis, be that within the hospital or community setting. Written or electronic recommendations should be tailored to the needs of the patient and family members,10 the organization and resources available. For example, there is an increasing trend towards the remote monitoring of patients or telemedicine.11,12

Telemedicine and palliative care in patients with advanced heart failure

The electronic transmission of physiological or haemodynamic data from the patient to the healthcare professional has been shown to improve compliance as well as enable early recognition of clinical deterioration with a positive impact on mortality and hospitalization.13 Nevertheless, implementation into European clinical practice remains limited due to diverse clinical outcomes seen in a number of different studies.14

The management plan should be evaluated in a timely manner and include components relating to the optimization of evidence-based medications, current clinical observations and biochemical markers, lifestyle advice including exercise,15 planned interventions,16–19 and information/education provided.20 According to European and American guidelines, the HF patient should be reviewed by the HF MDT face -to-face within 2 weeks of hospital discharge21 or by telephone contact within 3 days of hospital discharge.22 The who, when, and where should therefore ideally be defined prior to hospital discharge. For patients in the advanced stages of disease, the management plan should include details of palliative discussions, for example concerning the problems of frailty,23 and issues associated with ICD deactivation,24,25 do-not-resuscitate and preferred place of care.26 For many patients with advanced HF, due to poor mobility, financial implications or transport, long-term follow-up becomes increasingly reliant on the primary care physician and community teams. Good communication links between primary and secondary care are paramount for advice and support from the specialist HF team. Many nurses work across boundaries, with a recent systematic review and meta-analysis indicating their invaluable contribution enabling the HF patient to be cared for longer at home.27 This is of particular relevance when the foci of management changes to a more palliative approach, whereby the priority may switch to the need to maximize the quality of life.28

Two exemplar studies include the ‘Optimize heart failure program’, an initiative implemented in 45 countries, with the purpose to improve outcomes post-discharge. Using pre- and post-discharge checklists, as well as a printed smartphone application (‘My HF Passport’), positive preliminary results in terms of optimization of pharmacological therapy have been achieved.29 Similarly, the quality improvement programme created by the American Heart Association and the American Stroke Association, named ‘Get with the guidelines’, has yielded results in a 30-day reduction in HF readmissions.30

Finally, effective discharge planning can be beneficial to the healthcare professional, through improved confidence in the management of patients with advanced HF, particularly for those professionals working in general practice.31 Furthermore, a clear management plan facilitates the extended scope of nursing practice, for example in terms of medication adjustments, in accordance to defined protocols and the current literature.32–35

Conclusions

Effective care planning leads to improved outcomes in advanced HF patients and has the potential to positively impact clinical practice. It is an ongoing process from diagnosis to demise, and requires dedication and involvement from the HF multidisciplinary team, in a variety of healthcare settings. An effective care plan in advanced HF should include self-monitoring, lifestyle modification, diet, medication self-administration, follow-up treatment and palliative care, and should utilize every patient contact opportunity to improve care. Future studies should aim at specifically investigating the effectiveness of telemedicine systems and smartphone applications in advanced HF patients.36

Conflict of interest: none declared.

References

  • 1. https://medical-dictionary.thefreedictionary.com/care+plan (31 July 2019).
  • 2. Metra M. November 2018 at a glance: from prediction of heart failure in asymptomatic subjects to advanced chronic heart failure. Eur J Heart Fail 2018;20:1503–1504. [DOI] [PubMed] [Google Scholar]
  • 3. Basoor A, Doshi NC, Cotant JF, Saleh T, Todorov M, Choksi N, Patel KC, Degregorio M, Mehta RH, Halabi AR.. Decreased readmissions and improved quality of care with the use of an inexpensive checklist in heart failure. Congest Heart Fail 2013;19:200–206. [DOI] [PubMed] [Google Scholar]
  • 4. Lambrinou E, Kalogirou F, Lamnisos D, Sourtzi P.. Effectiveness of heart failure management programmes with nurse-led discharge planning in reducing re-admissions: a systematic review and meta-analysis. Int J Nurs Stud 2012;49:610–624. [DOI] [PubMed] [Google Scholar]
  • 5. Rosano G. Medical treatment of heart failure with reduced ejection fraction—aimed at reducing rehospitalisations. Int Cardiovasc Forum J 2017;10:29–33. [Google Scholar]
  • 6. McDonagh TA, Blue L, Clark AL, Dahlström U, Ekman I, Lainscak M, McDonald K, Ryder M, Strömberg A, Jaarsma T; European Society of Cardiology Heart Failure Association Committee on Patient Care . European Society of Cardiology Heart Failure Association Standards for delivering heart failure care. Eur J Heart Fail 2011;13:235–241. [DOI] [PubMed] [Google Scholar]
  • 7. Lopatin Y, Rosano G.. Treatment of patients in the vulnerable phase (at discharge or early after discharge). Int Cardiovasc Forum J 2017;10:37–40. [Google Scholar]
  • 8. Ulin K, Olsson LE, Wolf A, Ekman I.. Person-centred care—an approach that improves the discharge process. Eur J Cardiovasc Nurs 2016;15:e19–e26. [DOI] [PubMed] [Google Scholar]
  • 9. Mebazaa A, Yilmaz MB, Levy P, Ponikowski P, Peacock WF, Laribi S, Ristic AD, Lambrinou E, Masip J, Riley JP, McDonagh T, Mueller C, deFilippi C, Harjola VP, Thiele H, Piepoli MF, Metra M, Maggioni A, McMurray J, Dickstein K, Damman K, Seferovic PM, Ruschitzka F, Leite-Moreira AF, Bellou A, Anker SD, Filippatos G.. Recommendations on pre-hospital & early hospital management of acute heart failure: a consensus paper from the Heart Failure Association of the European Society of Cardiology, the European Society of Emergency Medicine and the Society of Academic Emergency Medicine. Eur J Heart Fail 2015;17:544–558. [DOI] [PubMed] [Google Scholar]
  • 10. Doherty LC, Fitzsimons D, McIlfatrick SJ.. Carers' needs in advanced heart failure: a systematic narrative review. Eur J Cardiovasc Nurs 2016;15:203–212. [DOI] [PubMed] [Google Scholar]
  • 11. Koehler F, Koehler K, Deckwart O, Prescher S, Wegscheider K, Winkler S, Vettorazzi E, Polze A, Stangl K, Hartmann O, Marx A, Neuhaus P, Scherf M, Kirwan BA, Anker SD.. Telemedical Interventional Management in Heart Failure II (TIM-HF2), a randomised, controlled trial investigating the impact of telemedicine on unplanned cardiovascular hospitalisations and mortality in heart failure patients: study design and description of the intervention. Eur J Heart Fail 2018;20:1485–1493. [DOI] [PubMed] [Google Scholar]
  • 12. Brahmbhatt DH, Cowie MR.. Remote management of heart failure: an overview of telemonitoring technologies. Card Fail Rev 2019;5:86–92. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Inglis SC, Clark RA, McAlister FA, Ball J, Lewinter C, Cullington D, Stewart S, Cleland JG.. Structured telephone support or telemonitoring programmes for patients with chronic heart failure. Cochrane Database Syst Rev 2010;8:CD007228. [DOI] [PubMed] [Google Scholar]
  • 14. Anker SD, Koehler F, Abraham WT.. Telemedicine and remote management of patients with heart failure. Lancet 2011;378:731–739. [DOI] [PubMed] [Google Scholar]
  • 15. Cornelis J, Myers J, Heidbuchel H, Vrints C, Beckers P.. Exercise training in heart failure patients with persistent atrial fibrillation: a practical approach. Card Fail Rev 2018;4:107–111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Lainscak M, Blue L, Clark AL, Dahlström U, Dickstein K, Ekman I, McDonagh T, McMurray JJ, Ryder M, Stewart S, Strömberg A, Jaarsma T.. Self-care management of heart failure: practical recommendations from the Patient Care Committee of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 2011;13:115–126. [DOI] [PubMed] [Google Scholar]
  • 17. Komajda M, Cowie MR, Tavazzi L, Ponikowski P, Anker SD, Filippatos GS.. Physicians' guideline adherence is associated with better prognosis in outpatients with heart failure with reduced ejection fraction: the QUALIFY international registry. Eur J Heart Fail 2017;19:1414–1423. [DOI] [PubMed] [Google Scholar]
  • 18. Ambrosy AP, Gheorghiade M.. Real-world dosing of evidence-based medications for heart failure: embracing guideline recommendations and clinical judgement. Eur J Heart Fail 2017;19:1424–1426. [DOI] [PubMed] [Google Scholar]
  • 19. McCarthy CP, Vaduganathan M, Pandey A.. Developing evidence-based and accountable health policy in heart failure. Eur J Heart Fail 2018;20:1653–1656. [DOI] [PubMed] [Google Scholar]
  • 20. www.heartfailurematters.org (31 July 2019).
  • 21. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, Falk V, González-Juanatey JR, Harjola V-P, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GMC, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P.. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur J Heart Fail 2016;18:891–975. [DOI] [PubMed] [Google Scholar]
  • 22. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJV, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WHW, Tsai EJ, Wilkoff BL; American College of Cardiology Foundation; American Heart Association Task Force on Practice Guidelines. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2013;62:e147–e239. [DOI] [PubMed] [Google Scholar]
  • 23. Vitale C, Spoletini I, Rosano GM.. Frailty in heart failure: implications for management. Card Fail Rev 2018;4:104–106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Hill L, McIlfatrick S, Taylor BJ, Dixon L, Cole BR, Moser DK, Fitzsimons D.. Implantable cardioverter defibrillator (ICD) deactivation discussions: reality versus recommendations. Eur J Cardiovasc Nurs 2016;15:20–29. [DOI] [PubMed] [Google Scholar]
  • 25. Spoletini I, Coats A.. Implantable cardioverter-defibrillators and cardiac resynchronization therapy in the treatment of heart failure with reduced ejection fraction. Int Cardiovasc Forum J 2017;10:41–44. [Google Scholar]
  • 26. Gerrard R, Campbell J, Minton O, Moback B, Skinner C, McGowan C, Stone PC.. Achieving the preferred place of care for hospitalized patients at the end of life. Palliat Med 2011;25:333–336. [DOI] [PubMed] [Google Scholar]
  • 27. Van Spall HGC, Rahman T, Mytton O, Ramasundarahettige C, Ibrahim Q, Kabali C, Coppens M, Brian Haynes R, Connolly S.. Comparative effectiveness of transitional care services in patients discharged from the hospital with heart failure: a systematic review and network meta-analysis. Eur J Heart Fail 2017;19:1427–1443. [DOI] [PubMed] [Google Scholar]
  • 28. Campbell RT, Petrie MC, McMurray J.. Talking to patients with heart failure about end of life. Eur J Heart Fail 2018;20:1763–1765. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Cowie MR, Lopatin YM, Saldarriaga C, Fonseca C, Sim D, Magaña JA, Albuquerque D, Trivi M, Moncada G, González Castillo BA, Sánchez MOS, Chung E.. The Optimize Heart Failure Care Program: initial lessons from global implementation. Int J Cardiol 2017;236:340–344. [DOI] [PubMed] [Google Scholar]
  • 30. Smaha LA, American H. Association The American Heart Association get with the guidelines program. Am Heart J 2004;148(5 Suppl):S46–S48. [DOI] [PubMed] [Google Scholar]
  • 31. Smeets M, Van Roy S, Aertgeerts B, Vermandere M, Vaes B.. Improving care for heart failure patients in primary care, GPs' perceptions: a qualitative evidence synthesis. BMJ Open 2016;6:e013459.. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. Blue L, McMurray J.. How much responsibility should heart failure nurses take? Eur J Heart Fail 2005;7:351–361. [DOI] [PubMed] [Google Scholar]
  • 33. Arrigo M, Nijst P, Rudiger A.. Optimising heart failure therapies in the acute setting. Card Fail Rev 2018;4:1–42. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34. Chioncel O, Collins SP, Greene SJ, Pang PS, Ambrosy AP, Antohi EL, Vaduganathan M, Butler J, Gheorghiade M.. Predictors of post-discharge mortality among patients hospitalized for acute heart failure. Card Fail Rev 2017;3:122–129. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. Garnier A, Rouiller N, Gachoud D, Nachar C, Voirol P, Griesser AC, Uhlmann M, Waeber G, Lamy O.. Effectiveness of a transition plan at discharge of patients hospitalized with heart failure: a before-and-after study. ESC Heart Fail 2018;5:657–667. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36. Packer M, Pitt B.. Future large-scale clinical trials in cardiovascular medicine: challenges and uncertainties. Eur J Heart Fail 2018;20:1645–1648. [DOI] [PubMed] [Google Scholar]

Articles from European Heart Journal Supplements : Journal of the European Society of Cardiology are provided here courtesy of Oxford University Press

RESOURCES